Navigation Links
Nelson Laboratories Compliant With New FDA Medical Device Registration Requirement

SALT LAKE CITY, Nov. 14, 2012 /PRNewswire/ -- Nelson Laboratories ( today announced compliance with the FDA Safety and Innovation Act (FDASIA) regarding updated requirements for the registration and listing of medical devices for contract sterilizers of non-exempt devices who do not commercially distribute product.


"Nelson Laboratories is committed to staying up to date on the latest regulations from the FDA," said Sherri L. Robbins, Nelson Laboratories Director of Regulatory Affairs. "Because we provide ethylene oxide batch release sterilization services for exempt and non-exempt medical devices, and do not commercially distribute product, we now fall under this regulation. Therefore, we have completed our registration with the FDA as a device establishment."

Part of this regulation change requires Nelson Laboratories to list the devices that they perform contract sterilization services on with the FDA. Contract sterilizers such as Nelson Laboratories can only complete a listing after the manufacturer has completed their own listing.

To know if you must register devices visit:

To continue receiving batch release sterilization services without delay, Nelson Laboratories' non-exempt medical device manufacturers need to register their devices on the FDA webpage that details "How To Register and List."

Before Nelson Laboratories can finish listing a device they will require the device exemption information for exempt devices, or for non-exempt devices, the 510(k), Premarket Approval (PMA) number and the proprietary marketed name of the device. Nelson Laboratories knows the importance of confidentiality and will always choose the "confidential" option when identifying the proprietary name of the device in FDA listing.

Anyone that has questions or needs additional guidance on registering a device can email Robbins at

About Nelson Laboratories

Nelson Laboratories is a leading provider of full, life-cycle microbiology testing services. We are known for exceptional quality, but we look beyond the testing process and partner with you to achieve your long-term business goals. It's what we call The Science of Success™. It's transparency in the testing process. It's approachable experts that guide you through ever-changing compliance requirements. It's helping you mitigate risk, be first to market, and succeed with your customers. Learn more at

Ryan Oaks
Snapp Conner PR

SOURCE Nelson Laboratories
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nelson Laboratories to Present Latest FDA Trends at MEDevice Forum San Diego
2. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
3. Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences
4. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
5. Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation
6. New Data Support Role of Prometheus Laboratories Novel Assay in Optimizing IBD Treatment Management
7. Everett Laboratories, Inc. Files Patent Infringement Lawsuit Against Competitor Trigen Laboratories, Inc.
8. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
9. Omega Laboratories Applauds the Adoption of Enzyme Immunoassay (EIA) by Major Hair Testing Laboratories
10. Court Preliminarily Deems Millennium Laboratories Press Release Misleading
11. Millennium Laboratories Wins Lawsuit: Ameritox Advertisements Regarding Rx Guardian and Rx Guardian CD Contain Literally False Statements
Post Your Comments:
(Date:12/1/2015)... BOSTON , December 1, 2015 Russia ... phase III clinical trials. 70% of new drugs registered in ... trials in Russia . --> Russia has ... trials. 70% of new drugs registered in Europe ... . --> Russia has always been ...
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology:
(Date:12/1/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... non-traumatic limb amputations in the United States. Podiatrists are well aware that psychology-based ... adopt therapeutic behaviors) are often catastrophic contributors to diseases of the diabetic foot. ...
(Date:12/1/2015)... ... December 01, 2015 , ... For the ... is why Hollister Incorporated has launched the VaPro Plus Pocket™ touch free hydrophilic ... the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice President North America. ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next IT Healthcare, the leader ... in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the ... finalist in the category of Digital Solutions for its innovative, industry-leading product, Alme ...
(Date:12/1/2015)... ... 2015 , ... TCS Healthcare Technologies (TCS), a leading provider ... is pleased to announce that VIP Care Services, a Caprock Health Group affiliate ... Complete Care™ Management to back their collaborative catastrophic case management initiatives. ACUITY Complete ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
Breaking Medicine News(10 mins):